Cardiomyocyte-restricted inhibition of G protein-coupled receptor kinase-3 attenuates cardiac dysfunction after chronic pressure overload

被引:14
|
作者
von Lueder, Thomas G. [1 ,3 ]
Gravning, Jorgen [1 ,3 ]
How, Ole-Jakob [4 ]
Vinge, Leif E. [1 ]
Ahmed, Mohammed Shakil [1 ]
Krobert, Kurt A. [2 ]
Levy, Finn Olav [2 ]
Larsen, Terje S. [4 ]
Smiseth, Otto A. [3 ,4 ]
Aasum, Ellen
Attramadal, Havard [1 ,3 ]
机构
[1] Univ Oslo, Rikshosp, Oslo Univ Hosp, Inst Surg Res, N-0027 Oslo, Norway
[2] Univ Oslo, Fac Med, Dept Pharmacol, N-0027 Oslo, Norway
[3] Univ Oslo, Rikshosp, Dept Cardiol, Oslo Univ Hosp, N-0027 Oslo, Norway
[4] Univ Tromso, Dept Med Physiol, Tromso, Norway
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2012年 / 303卷 / 01期
关键词
hypertrophy; heart failure; adrenergic receptor; aortic banding; BETA-GAMMA-SUBUNITS; FAILING HUMAN HEART; GENE-TARGETED MICE; PHOSPHOINOSITIDE; 3-KINASE; MYOCARDIAL-INFARCTION; TRANSGENIC MICE; FAILURE; EXPRESSION; HYPERTROPHY; SURVIVAL;
D O I
10.1152/ajpheart.00724.2011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
von Lueder TG, Gravning J, How O, Vinge LE, Ahmed MS, Krobert KA, Levy FO, Larsen TS, Smiseth OA, Aasum E, Attramadal H. Cardiomyocyte-restricted inhibition of G protein-coupled receptor kinase-3 attenuates cardiac dysfunction after chronic pressure overload. Am J Physiol Heart Circ Physiol 303: H66-H74, 2012. First published April 27, 2012; doi: 10.1152/ajpheart.00724.2011.-Transgenic mice with cardiac-specific expression of a peptide inhibitor of G protein-coupled receptor kinase (GRK)3 [transgenic COOH-terminal GRK3 (GRK3ct) mice] display myocardial hypercontractility without hypertrophy and enhanced alpha(1)-adrenergic receptor signaling. A role for GRK3 in the pathogenesis of heart failure (HF) has not been investigated, but inhibition of its isozyme, GRK2, has been beneficial in several HF models. Here, we tested whether inhibition of GRK3 modulated evolving cardiac hypertrophy and dysfunction after pressure overload. Weight-matched male GRK3ct transgenic and nontransgenic littermate control (NLC) mice subjected to chronic pressure overload by abdominal aortic banding (AB) were compared with sham-operated (SH) mice. At 6 wk after AB, a significant increase of cardiac mass consistent with induction of hypertrophy was found, but no differences between GRK3ct-AB and NLC-AB mice were discerned. Simultaneous left ventricular (LV) pressure-volume analysis of electrically paced, ex vivo perfused working hearts revealed substantially reduced systolic and diastolic function in NLC-AB mice (n = 7), which was completely preserved in GRK3ct-AB mice (n = 7). An additional cohort as subjected to in vivo cardiac catheterization and LV pressure-volume analysis at 12 wk after AB. NLC-AB mice (n = 11) displayed elevated end-diastolic pressure (8.5 +/- 3.1 vs. 2.9 +/- 1.2 mmHg, P < 0.05), reduced cardiac output (3,448 +/- 323 vs. 4,488 +/- 342 mu 1/min, P < 0.05), and reduced dP/dt(max) and dP/dt(min) (both P < 0.05) compared with GRK3ct-AB mice (n = 16), corroborating the preserved cardiac structure and function observed in GRK3ct-AB hearts assessed ex vivo. Increased cardiac mass and myocardial mRNA expression of beta-myosin heavy chain confirmed the similar induction of cardiac hypertrophy in both AB groups, but only NLC-AB hearts displayed significantly elevated mRNA levels of brain natriuretic peptide and myocardial collagen contents as well as reduced beta(1)-adrenergic receptor responsiveness to isoproterenol, indicating increased LV wall stress and the transition to HF. Inhibition of cardiac GRK3 in mice does not alter the hypertrophic response but attenuates cardiac dysfunction and HF after chronic pressure overload.
引用
收藏
页码:H66 / H74
页数:9
相关论文
共 50 条
  • [21] G protein-coupled receptor kinase 5 (GRK5) contributes to impaired cardiac function and immune cell recruitment in post-ischemic heart failure
    de Lucia, Claudio
    Grisanti, Laurel A.
    Borghetti, Giulia
    Piedepalumbo, Michela
    Ibetti, Jessica
    Lucchese, Anna Maria
    Barr, Eric W.
    Roy, Rajika
    Okyere, Ama Dedo
    Murphy, Haley Christine
    Gao, Erhe
    Rengo, Giuseppe
    Houser, Steven R.
    Tilley, Douglas G.
    Koch, Walter J.
    CARDIOVASCULAR RESEARCH, 2022, 118 (01) : 169 - 183
  • [22] Structural and Functional Analysis of G Protein-Coupled Receptor Kinase Inhibition by Paroxetine and a Rationally Designed Analog
    Homan, Kristoff T.
    Wu, Emily
    Wilson, Michael W.
    Singh, Puja
    Larsen, Scott D.
    Tesmer, John J. G.
    MOLECULAR PHARMACOLOGY, 2014, 85 (02) : 237 - 248
  • [23] Ischemic inactivation of G protein-coupled receptor kinase and altered desensitization of canine cardiac β-adrenergic receptors
    Yu, XC
    Zhang, M
    Kyker, K
    Patterson, E
    Benovic, JL
    Kem, DC
    CIRCULATION, 2000, 102 (20) : 2535 - 2540
  • [24] Obesity-induced cardiac lipid accumulation in adult mice is modulated by G protein-coupled receptor kinase 2 levels
    Lucas, Elisa
    Vila-Bedmar, Rocio
    Arcones, Alba C.
    Cruces-Sande, Marta
    Cachofeiro, Victoria
    Mayor, Federico, Jr.
    Murga, Cristina
    CARDIOVASCULAR DIABETOLOGY, 2016, 15
  • [25] G Protein-Coupled Receptor Kinase-5 Attenuates Atherosclerosis by Regulating Receptor Tyrosine Kinases and 7-Transmembrane Receptors
    Wu, Jiao-Hui
    Zhang, Lisheng
    Fanaroff, Alexander C.
    Cai, Xinjiang
    Sharma, Krishn C.
    Brian, Leigh
    Exum, Sabrina T.
    Shenoy, Sudha K.
    Peppel, Karsten
    Freedman, Neil J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (02) : 308 - U325
  • [26] G Protein-Coupled Receptor Kinase 2 Activity Impairs Cardiac Glucose Uptake and Promotes Insulin Resistance After Myocardial Ischemia
    Ciccarelli, Michele
    Chuprun, J. Kurt
    Rengo, Giuseppe
    Gao, Erhe
    Wei, Zhengyu
    Peroutka, Raymond J.
    Gold, Jessica I.
    Gumpert, Anna
    Chen, Mai
    Otis, Nicholas J.
    Dorn, Gerald W., II
    Trimarco, Bruno
    Iaccarino, Guido
    Koch, Walter J.
    CIRCULATION, 2011, 123 (18) : 1953 - U245
  • [27] Partial inhibition of activin receptor-like kinase 4 attenuates pressure overload-induced cardiac fibrosis and improves cardiac function
    Li, Chang-Yi
    Chen, Yi-He
    Wang, Qian
    Hou, Jian-Wen
    Wang, Hong
    Wang, Yue-Peng
    Li, Yi-Gang
    JOURNAL OF HYPERTENSION, 2016, 34 (09) : 1766 - 1777
  • [28] Nuclear Translocation of Cardiac G Protein-Coupled Receptor Kinase 5 Downstream of Select Gq-Activating Hypertrophic Ligands Is a Calmodulin-Dependent Process
    Gold, Jessica I.
    Martini, Jeffrey S.
    Hullmann, Jonathan
    Gao, Erhe
    Chuprun, J. Kurt
    Lee, Linda
    Tilley, Douglas G.
    Rabinowitz, Joseph E.
    Bossuyt, Julie
    Bers, Donald M.
    Koch, Walter J.
    PLOS ONE, 2013, 8 (03):
  • [29] G Protein-coupled Receptor Kinase 5 Phosphorylates Nucleophosmin and Regulates Cell Sensitivity to Polo-like Kinase 1 Inhibition
    So, Christopher H.
    Michal, Allison M.
    Mashayekhi, Rouzbeh
    Benovic, Jeffrey L.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (21) : 17088 - 17099
  • [30] The G Protein-Coupled Receptor PAC1 Regulates Transactivation of the Receptor Tyrosine Kinase HER3
    Moody, Terry W.
    Lee, Lingaku
    Jensen, Robert T.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2021, 71 (08) : 1589 - 1597